This episode explores a key moment in medical aesthetics: the FDA's approval of XEOMIN® (incobotulinumtoxinA) for the simultaneous treatment of forehead lines, frown lines, and crow's feet. Initially approved in 2011 for frown lines, XEOMIN® now expands its scope, offering a comprehensive solution for upper facial lines. Hear from Merz Aesthetics' Chief Scientific Officer, Dr. Samantha Kerr, and President of North America, Patrick Urban, about the product's unique formulation and the technology behind its effectiveness. Celebrity endorsement by Demi Lovato underscores XEOMIN®'s appeal for natural-looking, lasting results. This episode provides insights into the clinical studies validating its safety and efficacy and shares information on how to find a provider. Tune in to understand what this means for the future of facial aesthetics.

Stay connected with Dr. Teri Fisher and explore the latest in AI and automation for healthcare:

🎥 Watch on YouTube for in-depth AI tutorials: YouTube.com/@DrTeriFisher
📲 Follow on Instagram for automation tips: @DrTeriFisher
💡 Discover AI tools for your practice: DrTeriFisher.com
🎙 Listen to the long-form podcast: Anti-Aging Insights

👉 Subscribe to AI Automation Minute for your daily dose of AI-powered efficiency, and share with colleagues who want to work smarter, not harder!

#AIAutomationMinute #DrTeriFisher #HealthcareAI